How to Get Retatrutide in 2026

The hype is justified: retatrutide's Phase 2 trial (Jastreboff et al., NEJM 2023) showed up to 24% body weight loss, making it the most effective weight loss medication ever tested. Naturally, patients want access now. But navigating the current landscape -- where the drug is not yet FDA-approved and various sources of varying legitimacy claim to offer it -- requires careful consideration. Here is an honest assessment of your options.

Option 1: Clinical Trial Enrollment

The most rigorous way to access retatrutide is through Eli Lilly's Phase 3 TRIUMPH clinical trial program. Trial participants receive the medication at no cost, with comprehensive medical monitoring, regular lab work, and expert oversight. The drawbacks include strict eligibility criteria, the possibility of receiving placebo, required clinic visits on a set schedule, and geographic limitations (trials are conducted at specific research sites).

To search for active trials, visit ClinicalTrials.gov and search for "retatrutide" or "LY3437943." Your primary care physician or endocrinologist can help determine if you meet eligibility criteria and refer you to a participating site.

Option 2: Compounding Pharmacies

Some compounding pharmacies have begun offering compounded retatrutide with a physician prescription. This is a legal pathway under FDA regulations that allow pharmacies to compound medications that are not commercially available. However, quality varies enormously between pharmacies. Only use pharmacies that are state-licensed and regularly inspected, follow current Good Manufacturing Practices (cGMP), provide certificates of analysis with third-party testing, have a track record with other compounded peptides, and are transparent about their sourcing and processes.

Option 3: Wait for FDA Approval

The safest and most assured access pathway is waiting for FDA approval, expected in late 2027 or 2028. At that point, brand-name retatrutide would be available by prescription at retail pharmacies with the full backing of FDA quality standards, comprehensive prescribing information, and established safety data from Phase 3 trials.

What to Do Right Now

While retatrutide completes clinical development, highly effective weight loss treatments are available today. Compounded semaglutide (from $99/mo) produces 15-17% weight loss, and compounded tirzepatide (from $125/mo) produces 20-22% weight loss. These are well-characterized medications with years of clinical data supporting their safety and efficacy.

Starting treatment now with semaglutide or tirzepatide allows you to begin your weight loss journey immediately, establish healthy lifestyle habits that will compound with any future medication, and potentially transition to retatrutide later if it offers additional benefit for your situation.

To get started with currently available treatments, visit our treatments page.